Costs Of Accountable Care Organization Antitrust Oversight Could Hinder Participation
This article was originally published in The Gray Sheet
Executive Summary
Health care attorneys and others pressed Federal Trade Commission officials last week to revise proposed oversight plans of accountable care organizations to better promote participation in the ACO program.
You may also be interested in...
MedPAC Weighs In On Medicare Accountable Care Organization Proposal
The success of the Medicare shared savings program should not be measured by counting how many accountable care organizations participate in the initial agreement period next year, according to the Medicare Payment Advisory Commission.
MedPAC Weighs In On Medicare Accountable Care Organization Proposal
The success of the Medicare shared savings program should not be measured by counting how many accountable care organizations participate in the initial agreement period next year, according to the Medicare Payment Advisory Commission.
Debate Heats Up On Antitrust Issues Surrounding Medicare Accountable Care Organization Program
The medical device industry wants the Federal Trade Commission and U.S. Department of Justice to stand firm in their plan to screen out anticompetitive accountable care organizations from the Medicare Shared Savings Program.